Representatives from Actelion Pharmaceuticals Ltd will be presenting data from its Phase III GRIPHON and SERAPHIN studies at the American…
Maureen Newman
Maureen Newman is a science columnist for Pulmonary Hypertension News. She is currently a PhD student studying biomedical engineering at University of Rochester, working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit's laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Maureen Newman
Long-term results for the GRIPHON trial are in. According to a presentation made at the…
A lot can change in five years, especially when someone has chronic thromboembolic pulmonary hypertension (CTEPH). A group…
Patients with pulmonary hypertension who require a lung transplant are expected to move to higher priority on the wait…
Tiny biomarkers for pulmonary hypertension in patients with systemic sclerosis (SSc) may be floating around affected individuals’ bloodstreams. Matthew…
Adding to the list of medical conditions that may result in pulmonary hypertension is the rare artery disease known…
The right ventricle is extremely critical to the progression of pulmonary hypertension due to its position immediately before the…
Although right heart catheterization is an invasive procedure, it can detect changes in right ventricular volume that predict clinical…
Courtesy of EchoSense Two clinical trials from EchoSense Ltd. are directed toward using lung Doppler signals…
Bayer is sponsoring a long-term observational clinical trial involving patients with pulmonary hypertension or pulmonary arterial hypertension due to…
Treating patients with systemic sclerosis (SSc) who have borderline pulmonary arterial hypertension (PAH) is vital to patient health, as…
Clinicians, scientists, and researchers have acknowledged an association between systemic sclerosis (SSc) and pulmonary arterial hypertension, and have even…